Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Turesson

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|February 1, 1992
Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG)F Wisløff, P Gimsing, M Hedenus, et al.
European Journal of Haematology|September 13, 2002
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulationT Nilsson, S Lenhoff, I Turesson, et al.
British Journal of Haematology|June 3, 1998
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study groupH Brincker, J Westin, N Abildgaard, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
British Journal of Haematology|December 3, 1999
Identification of patient-specific peptides for detection of M-proteins and myeloma cellsP B Szecsi, E Riise, L B Roslund, et al.
Genes, Chromosomes & Cancer|September 1, 1995
Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignanciesB Johansson, K Arheden, M Höglund, et al.
The Journal of Pharmacy and Pharmacology|January 24, 2004
Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysisT Eriksson, P Höglund, I Turesson, et al.
Clinical and Experimental Immunology|July 1, 1987
A sulfhydryl-rich IgM protein with multiple serological specificitiesG Merlini, O Zettervall, A Forsgren, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1995
Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancerW A Brock, S L Tucker, F B Geara, et al.
Scandinavian Journal of Infectious Diseases|October 28, 1998
Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidimeR Lindblad, S Rödjer, M Adriansson, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|February 1, 1992
Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG)F Wisløff, P Gimsing, M Hedenus, et al.
European Journal of Haematology|September 13, 2002
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulationT Nilsson, S Lenhoff, I Turesson, et al.
British Journal of Haematology|June 3, 1998
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study groupH Brincker, J Westin, N Abildgaard, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
British Journal of Haematology|December 3, 1999
Identification of patient-specific peptides for detection of M-proteins and myeloma cellsP B Szecsi, E Riise, L B Roslund, et al.
Genes, Chromosomes & Cancer|September 1, 1995
Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignanciesB Johansson, K Arheden, M Höglund, et al.
The Journal of Pharmacy and Pharmacology|January 24, 2004
Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysisT Eriksson, P Höglund, I Turesson, et al.
Clinical and Experimental Immunology|July 1, 1987
A sulfhydryl-rich IgM protein with multiple serological specificitiesG Merlini, O Zettervall, A Forsgren, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1995
Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancerW A Brock, S L Tucker, F B Geara, et al.
Scandinavian Journal of Infectious Diseases|October 28, 1998
Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidimeR Lindblad, S Rödjer, M Adriansson, et al.
Pageof 12